Found: 29
Select item for more details and to access through your institution.
Clinical Pharmacology: Pharmacogenetics: Opportunities for Patient-Tailored Anticancer Therapy Part 4: Pharmacogenetic Variability in Anticancer Pharmacodynamic Drug Effects.
- Published in:
- Oncologist, 2011, v. 16, n. 7, p. 1006, doi. 10.1634/theoncologist.2010-0261
- By:
- Publication type:
- Article
Clinical Pharmacology: Pharmacogenetics: Opportunities for Patient-Tailored Anticancer Therapy Part 3: Pharmacogenetic Variability in Phase II Anticancer Drug Metabolism.
- Published in:
- Oncologist, 2011, v. 16, n. 7, p. 992, doi. 10.1634/theoncologist.2010-0260
- By:
- Publication type:
- Article
Clinical Pharmacology: Pharmacogenetics: Opportunities for Patient-Tailored Anticancer Therapy Part 1: Background, Methodology, and Clinical Adoption of Pharmacogenetics.
- Published in:
- Oncologist, 2011, v. 16, n. 6, p. 811, doi. 10.1634/theoncologist.2010-0258
- By:
- Publication type:
- Article
Clinical Pharmacology: Pharmacogenetics: Opportunities for Patient-Tailored Anticancer Therapy Part 2: Pharmacogenetic Variability in Drug Transport and Phase I Anticancer Drug Metabolism.
- Published in:
- Oncologist, 2011, v. 16, n. 6, p. 820, doi. 10.1634/theoncologist.2010-0259
- By:
- Publication type:
- Article
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 603, p. 1, doi. 10.1126/scitranslmed.abf3637
- By:
- Publication type:
- Article
Is vancomycin clearance really correlated with hemoglobin? Arguments that it's not.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 7, p. 921, doi. 10.1007/s00228-019-02657-6
- By:
- Publication type:
- Article
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 6, p. 737, doi. 10.1007/s00228-018-2426-4
- By:
- Publication type:
- Article
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919838964
- By:
- Publication type:
- Article
Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919838964
- By:
- Publication type:
- Article
Standard-dose tegafur-uracil (UFT) is not a safe alternative in partial dihydropyrimidine dehydrogenase-deficient patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2013, v. 5, n. 1, p. 91, doi. 10.1177/1758834012464806
- By:
- Publication type:
- Article
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetics of Capecitabine and Four Metabolites in a Heterogeneous Population of Cancer Patients: A Comprehensive Analysis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 12, p. 940, doi. 10.1002/psp4.12474
- By:
- Publication type:
- Article
Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC).
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 9, p. 5311, doi. 10.1245/s10434-020-09558-4
- By:
- Publication type:
- Article
Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 1, p. 265, doi. 10.1245/s10434-020-08743-9
- By:
- Publication type:
- Article
A Nomogram to Predict Severe Toxicity in DPYD Wild‐Type Patients Treated With Capecitabine‐Based Anticancer Regimens.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 269, doi. 10.1002/cpt.3100
- By:
- Publication type:
- Article
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old woman.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 9, p. 2120, doi. 10.1111/bcp.13309
- By:
- Publication type:
- Article
Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 3, p. 706, doi. 10.1111/bcp.13007
- By:
- Publication type:
- Article
Identification of Medication-Related Risks in Bariatric Surgery Patients by Performing Structured Medication Reviews.
- Published in:
- Obesity Surgery, 2023, v. 33, n. 12, p. 3932, doi. 10.1007/s11695-023-06889-5
- By:
- Publication type:
- Article
Standard-Dose Tegafur Combined With Uracil Is Not Safe Treatment After Severe Toxicity From 5-Fluorouracil or Capecitabine.
- Published in:
- Annals of Internal Medicine, 2010, v. 153, n. 11, p. 767, doi. 10.7326/0003-4819-153-11-201012070-00023
- By:
- Publication type:
- Article
The Effect of Genotyping on the Number of Pharmacotherapeutic Gene–Drug Interventions in Chronic Kidney Disease Patients.
- Published in:
- Pharmacy, 2023, v. 11, n. 2, p. 69, doi. 10.3390/pharmacy11020069
- By:
- Publication type:
- Article
An Evidence-Based Rationale for Dose De-escalation of Subcutaneous Atezolizumab.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 5, p. 779, doi. 10.1007/s11523-024-01087-4
- By:
- Publication type:
- Article
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 3, p. 441, doi. 10.1007/s11523-023-00958-6
- By:
- Publication type:
- Article
Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.577968
- By:
- Publication type:
- Article
Effectiveness and safety of reduced‐dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysis.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 9, p. 2347, doi. 10.1002/ijc.32022
- By:
- Publication type:
- Article
Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 11, p. 2752, doi. 10.1002/ijc.30014
- By:
- Publication type:
- Article
Increased risk of severe fluoropyrimidine-associated toxicity in patients carrying a G to C substitution in the first 28-bp tandem repeat of the thymidylate synthase 2 R allele.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 1, p. 245, doi. 10.1002/ijc.29694
- By:
- Publication type:
- Article
Standard-Dose Trifluridine/Tipiracil as Safe Treatment Alternative in Metastatic Colorectal Cancer Patients With DPD Deficiency.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 359, doi. 10.1016/j.clcc.2021.09.004
- By:
- Publication type:
- Article